Market Research Logo

Scopolamine Market - Size, Share, Trends, and Forecast to 2026

Scopolamine Market - Size, Share, Trends, and Forecast to 2026

Scopolamine is an oral, intravenous, ophthalmic or topical drug derived from plants of the nightshade family (Solanaceae), specifically Hyoscyamus Niger and Atropa belladonna, with anticholinergic, antiemetic and antivertigo properties.
It has applications in prevention of nausea, vomiting, and dizziness associated with motion sickness and recovery from anesthesia and surgery. Scopolamine may also be used to treat certain stomach or intestinal problems, such as spastic muscle states, diverticulitis, irritable bowel syndrome, Parkinson-like conditions etc.
Market Dynamics
Changing lifestyle that involves minimal or absolutely no physical work in a routine life are responsible for the malfunctioning of the digestive as well as gastrointestinal system. Increasing number of population adopting long-hour sedentary work lifestyle are likely to be affected with gastrointestinal disorders such as irritable bowel syndrome and thus are responsible to support growth of the global scopolamine market.
However, various side-effects observed while using these drugs such as retarded motion, drowsiness, and diluted pupils, may limit their growth to some extent in the near future.
Key features of the study:

This report provides in-depth analysis of the scopolamine market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global scopolamine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Baxter International Inc., GlaxoSmithKline plc, Novartis AG, Perrigo Company plc, Caleb Pharmaceuticals, Inc., Myungmoon Pharma Co. LTD., Alchem International, Phytex Australia, Centroflora-Cms, Alkaloids of Australia, and Fine Chemicals Corporation.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global scopolamine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for scopolamine market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Scopolamine Market, By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

Global Scopolamine Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Scopolamine Market, By Region:

North America

By Country:

U.S.
Canada

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Europe

By Country:

U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Asia Pacific

By Country:

Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Latin America

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Middle East

By Country:

GCC
Israel
Rest of Middle East

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Africa

By Country:

South Africa
Central Africa
North Africa

By Dosage Form:

Tablet
Syrup
Injection
Patch
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Company Profiles

Baxter International Inc.*

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

GlaxoSmithKline plc
Novartis AG
Perrigo Company plc.
Caleb Pharmaceuticals, Inc.
Myungmoon Pharma Co. LTD.
Alchem International
Phytex Australia
Centroflora-Cms
Alkaloids of Australia
Fine Chemicals Corporation

“*” marked represents similar segmentation in other categories in the respective section.


Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Dosage Form
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Epidemiology
Historical Overview
Revenue Potential of Drugs
PORTER’S Five Forces
PEST Analysis
Global Scopolamine Market, By Dosage Form, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Tablet
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Syrup
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Injection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Patch
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Global Scopolamine Market, By Distribution Channel, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Global Scopolamine Market, By Regions, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2016 – 2026
Regional Trends
North America
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Northern Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
Competitive Landscape
Heat Map Analysis
Company Profiles
Baxter International Inc.
Company Overview
Dosage Form Portfolio
Financial Performance
Recent Highlights
Strategies
GlaxoSmithKline plc
Company Overview
Dosage Form Portfolio
Financial Performance
Recent Highlights
Strategies
Novartis AG
Company Overview
Dosage Form Portfolio
Financial Performance
Recent Highlights
Strategies
Perrigo Company plc.
Company Overview
Dosage Form Portfolio
Financial Performance
Recent Highlights
Strategies
Caleb Pharmaceuticals, Inc.
Company Overview
Dosage Form Portfolio
Financial Performance
Recent Highlights
Strategies
Myungmoon Pharma Co. LTD.
Company Overview
Dosage Form Portfolio
Financial Performance
Recent Highlights
Strategies
Alchem International
Company Overview
Dosage Form Portfolio
Financial Performance
Recent Highlights
Strategies
Phytex Australia
Company Overview
Dosage Form Portfolio
Financial Performance
Recent Highlights
Strategies
Centroflora-Cms
Company Overview
Dosage Form Portfolio
Financial Performance
Recent Highlights
Alkaloids of Australia
Company Overview
Dosage Form Portfolio
Financial Performance
Recent Highlights
Strategies
Fine Chemicals Corporation
Company Overview
Dosage Form Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
Section
References
Research Methodology
About us and Sales Contact
*Browse 19 market data tables and 23 figures on \Scopolamine Market” - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report